Trinity Biotech | TRIB - Cost Of Sales


Trinity Biotech reported $7.17M in Cost of Sales for its fiscal quarter ending in December of 2025.





Cost Of Sales Change Date
Abbott USD 5.94B 642M Jun/2026
Bayer EUR 4.54B 692M Jun/2026
Bio-Rad Laboratories USD 305.2M 22.5M Jun/2026
EDAP TMS EUR 9.67M 1.76M Mar/2026
J&J USD 8B 67M Jun/2026
Mesa Laboratories USD 21.92M 1.78M Sep/2024
OraSure Technologies USD 15.43M 113K Dec/2025
Roche Holding CHF 7.85B 630M Jun/2026
Siemens EUR 12.29B 218M Jun/2026
Thermo Fisher Scientific USD 7.54B 577M Jun/2026
Tosoh JPY 199.55B 5.82B Jun/2026
Trinity Biotech USD 7.17M 666K Dec/2025
Veracyte USD 42.19M 3.7M Jun/2026